FOXO Technologies Inc. (FOXO)
US — Healthcare Sector
Automate Your Wheel Strategy on FOXO
With Tiblio's Option Bot, you can configure your own wheel strategy including FOXO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol FOXO
- Rev/Share 0.2773
- Book/Share 360.7851
- PB 0.0005
- Debt/Equity 0.0027
- CurrentRatio 88.0382
- ROIC -0.0002
- MktCap 2119872.0
- FreeCF/Share -0.2199
- PFCF -0.6598
- PE -0.2351
- Debt/Assets 0.0003
- DivYield 0
- ROE -0.0094
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 5
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About FOXO Technologies Inc. (FOXO)
- IPO Date 2022-09-16
- Website https://www.foxotechnologies.com
- Industry Medical - Healthcare Information Services
- CEO Seamus Lagan
- Employees 102
FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.